ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0157

Development of a Deep Learning Algorithm for the Detection of Sacroiliitis on MRI in Patients with Active Axial Spondyloarthritis

Joeri Nicolaes1, Pedro Machado2, Xenofon Baraliakos3, Mayank Santosh4, Andrew Carnell4, Natasha de Peyrecave4 and Alexander Bennett5, 1UCB Pharma, Brussels, Belgium; Medical Image Computing, ESAT-PSI, Department of Electrical Engineering, KU Leuven, Leuven, Belgium, 2Centre for Rheumatology & Department of Neuromuscular Diseases, University College London, London, United Kingdom, 3Rheumazentrum Ruhrgebiet Herne, Ruhr-Universität Bochum, Herne, Germany, 4UCB Pharma, Brussels, Belgium, 5Academic Department of Military Rehabilitation, Defence Medical Rehabilitation Centre Headley Court, Epsom, UK; National Heart and Lung Institute, Faculty of Medicine, Imperial College London, London, United Kingdom

Meeting: ACR Convergence 2021

Keywords: Ankylosing spondylitis (AS), Magnetic resonance imaging (MRI), spondyloarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 6, 2021

Title: Imaging of Rheumatic Diseases Poster (0149–0182)

Session Type: Poster Session A

Session Time: 8:30AM-10:30AM

Background/Purpose: Magnetic resonance imaging (MRI) plays a critical role in assisting the diagnosis of axial spondyloarthritis (axSpA). There are many characteristic MRI lesions that can be present in patients with axSpA; these have been well characterized in the literature,1 and, alongside clinical presentation and laboratory features, can be used to assist diagnosis. However, in-depth knowledge of these lesions and their definitions, as well as reliability of identification and scoring, varies amongst general radiologists and rheumatologists.2 The use of artificial intelligence to develop automated recognition of MRI lesions associated with axSpA has the potential to vastly improve diagnosis of this condition. We present a data-driven approach to automatically detect sacroiliitis on MRI.

Methods: We built a training database of de-identified sacroiliac joint (SIJ) MRI scans containing short tau inversion recovery (STIR) and T1 sequences acquired on 12 scanner models from three vendors (50% Siemens, 46% GE and 4% Philips). This dataset contains baseline MRI images from 202 patients (mean age: 38 years [range: 18–74]; 52% male) scanned at 34 clinical sites in 7 countries (97% from Europe) from interventional studies in patients with axSpA (C-axSpAnd [NCT02552212], BE MOBILE 1 [NCT03928704] and BE MOBILE 2 [NCT03928743]). 85% of the images were from patients with non-radiographic axSpA. Informed consent was collected from all patients for these studies. Three expert readers independently and manually delineated bone marrow edema (BME) lesions in a subset of cases. A positive case was defined as a patient with one or more BME lesions. We developed a two-stage lesion detection pipeline: firstly, a deep learning model binary classified each voxel present in the 3D image as either a normal or BME lesion (mimicking the reader’s delineations); secondly, this voxel-level information was aggregated to a binary case-level prediction (positive if one or more BME lesions were predicted). The time to read one patient was < 0.5 min. We then performed a stratified 7-fold cross-validation experiment comparing the automated predictions with ground truth read-outs from the readers.

Results: A total of 280 lesions in 116 BME-positive patients were identified. The presented method achieved case-level BME lesion detection results of 77% area under the receiver operating characteristic (ROC) curve (95% confidence interval [CI]: 71% to 83%; Figure 1), 74% specificity (95% CI: 64% to 83%), 70% sensitivity (95% CI: 62% to 78%) and 79% precision (95% CI: 71% to 86%).

Conclusion: Using MRI images from 202 patients, our automated method achieved robust case-level BME lesion detection results. This methodology has the potential to support radiologists and rheumatologists in detecting BME lesions on MRI scans to aid early and accurate diagnosis of axSpA. Further investigations, including confirmatory analyses and methodological improvements and validation, are warranted.

References: 1.Maksymowych WP. Ann Rheum Dis 2019; 78: 1550–58; 2. Bennett AN. J Rheumatol 2017; 44: 780–5.


Disclosures: J. Nicolaes, UCB Pharma, 3; P. Machado, Abbvie, 6, BMS, 6, Celgene, 6, Eli Lilly, 2, Janssen, 2, MSD, 6, Galapagos, 6, Novartis, 2, 6, Pfizer, 6, Roche, 6, UCB, 2, 6, Orphazyme, 5, 6; X. Baraliakos, AbbVie, 2, 5, 6, Chugai, 2, 5, 6, Novartis, 2, 5, 6, Pfizer, 2, 5, 6, UCB, 2, 5, 6, Bristol-Myers Squibb, 2, 5, 6, Celegene, 2, 5, 6, Merck, 2, 6, Werfen, 2; M. Santosh, UCB Pharma, 3; A. Carnell, UCB Pharma, 7; N. de Peyrecave, UCB Pharma, 3, 11; A. Bennett, None.

To cite this abstract in AMA style:

Nicolaes J, Machado P, Baraliakos X, Santosh M, Carnell A, de Peyrecave N, Bennett A. Development of a Deep Learning Algorithm for the Detection of Sacroiliitis on MRI in Patients with Active Axial Spondyloarthritis [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/development-of-a-deep-learning-algorithm-for-the-detection-of-sacroiliitis-on-mri-in-patients-with-active-axial-spondyloarthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/development-of-a-deep-learning-algorithm-for-the-detection-of-sacroiliitis-on-mri-in-patients-with-active-axial-spondyloarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology